FWM
ABMD

Filbrandt Wealth Management’s Abiomed Inc ABMD Stock Holding History

Filbrandt Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
+2
New +$678 ﹤0.01% 233

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Filbrandt Wealth Management's ABMD Position: Q3 2021 in Review

Filbrandt Wealth Management opened a new position in Abiomed Inc (ABMD) in Q3 2021: 2 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #233 among its holdings.

498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Filbrandt Wealth Management held 2 shares of Abiomed Inc worth $1K as of Q3 2021.
  • Abiomed Inc was a new Filbrandt Wealth Management position in Q3 2021.
  • Abiomed Inc made up ﹤0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #233 holding.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.